Viewing Study NCT03783403

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-03-05 @ 7:06 PM
Study NCT ID: NCT03783403
Status: TERMINATED
Last Update Posted: 2024-09-19
First Post: 2018-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPĪ±, in Participants With Advanced Solid and Hematologic Cancers
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CC-95251 View
None Antibody View
None SIRPĪ± View
None Advanced Solid Cancers View
None Advanced Hematologic Cancers View